A matching sterile product (Placebo Ophthalmic Solution) will be provided using the same excipient formulation as the active K-321 product., Ripasudil
K-321-301
Phase 3 small_molecule active
Quick answer
A matching sterile product (Placebo Ophthalmic Solution) will be provided using the same excipient formulation as the active K-321 product., Ripasudil for Fuchs Endothelial Corneal Dystrophy is a Phase 3 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Institut für biomedizinische Analytik NMR-Imaging GmbH
- Indication
- Fuchs Endothelial Corneal Dystrophy
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active